(Q34517666)

2 August 2017

title

Clofibrate and diabetes control in patients treated with oral hypoglycaemic agents (English)

1 reference

2 August 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1979.TB04649.X

27 June 2022

author name string

J. C. Daubresse

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A380614

27 June 2022

D. Daigneux

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A380614

27 June 2022

M. Bruwier

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A380614

27 June 2022

A. Luyckx

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A380614

27 June 2022

P. J. Lefebvre

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A380614

27 June 2022

language of work or name

English

0 references

publication date

1 June 1979

1 reference

full work available at URL

2 August 2017

https://europepmc.org/articles/PMC1429683

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A380614

https://europepmc.org/articles/PMC1429683?pdf=render

27 June 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A380614

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1979.tb04649.x

27 June 2022

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1111/J.1365-2125.1979.TB04649.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1979.tb04649.x/fullpdf

27 June 2022

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1111/J.1365-2125.1979.TB04649.X

British Journal of Clinical Pharmacology

27 June 2022

published in

1 reference

2 August 2017

volume

7

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

599-603

1 reference

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

2 August 2017

cites work

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429683

7 July 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429683

Laboratory indices in clofibrate therapy of juvenile-onset diabetes

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429683

Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429683

Control of diabetes: An attempt to formulate policy guidelines in a department of medicine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429683

Drugs and Lipid Metabolism

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429683

Potentiation of Hypoglycemic Effect of Sulfonylureas by Clofibrate

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429683

Effect of clofibrate on glucose tolerance in maturity onset diabetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429683

Effects of short-term clofibrate administration on glucose tolerance and insulin secretion in patients with chemical diabetes or hypertriglyceridemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429683

Metabolic effects of clofibrate in insulin-dependent ketosis-prone diabetic man

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429683

The Effect of Clofibrate on Glucose Tolerance, Insulin Secretion, Triglycerides and Fibrinogen in Patients with Coronary Heart Disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429683

Effect of clofibrate on glucose tolerance and insulin secretion in patients with endogenous hypertriglyceridemia (author's transl)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429683

Potentiation of Hypoglycemic Effect of Sulfonylureas by Halofenate

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429683

THE M-VALVE, AN INDEX OF BLOOD-SUGAR CONTROL IN DIABETICS

7 July 2018

1 reference

12 December 2020

ATROMID IN THE TREATMENT OF POST-CLIMACTERIC DIABETES

1 reference

12 December 2020

EXPERIENCE WITH ATROMID IN VARIOUS HYPERCHOLESTEROLAEMIC STATES AND DIABETES MELLITUS

1 reference

12 December 2020

THE EFFECT OF ATROMID ON SERUM CHOLESTEROL AND GLUCOSE TOLERANCE IN DIABETES MELLITUS

1 reference

12 December 2020

AN EXPERIMENTAL APPROACH TO THE PROBLEM OF DISORDERED LIPID METABOLISM

1 reference

12 December 2020

Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose

1 reference

12 December 2020

Micromethod for the direct determination of serum triglycerides

1 reference

12 December 2020

Inhibitory effect of clofibrate on arginine-induced insulin secretion in chemical diabetes

1 reference

12 December 2020

Ethyl chlorophenoxyisobutyrate (CPIB) effects in juvenile-onset diabetes mellitus

1 reference

12 December 2020

Long-term monitoring during clofibrate therapy

1 reference

12 December 2020

Hypolipidemic effect of chlorophenoxyisobutyrate in adult-onset diabetes mellitus

1 reference

12 December 2020

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference